A real-world experience of pembrolizumab monotherapy in microsatellite instability-high and/or tumor mutation burden-high metastatic castration-resistant prostate cancer: outcome analysis
Osama Mosalem, Winston Tan, Alan H. Bryce, Roxana Dronca, Daniel S. Childs, Lance C. Pagliaro, Jacob J. Orme, Adam M. Kase
Topics & Concepts
PembrolizumabMedicineProstate cancerMicrosatellite instabilityInternal medicineOncologyBiopsyCancerLiquid biopsyUrologyGastroenterologyImmunotherapyMicrosatelliteChemistryAlleleBiochemistryGeneProstate Cancer Treatment and ResearchCancer Immunotherapy and BiomarkersProstate Cancer Diagnosis and Treatment